A detailed history of State Street Corp transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, State Street Corp holds 95,004 shares of RMTI stock, worth $236,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,004
Previous 78,204 21.48%
Holding current value
$236,559
Previous $137,000 175.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.67 - $4.4 $28,056 - $73,920
16,800 Added 21.48%
95,004 $377,000
Q2 2024

Aug 14, 2024

BUY
$1.45 - $1.92 $5,655 - $7,488
3,900 Added 5.25%
78,204 $137,000
Q4 2023

Feb 14, 2024

BUY
$1.58 - $2.44 $64,306 - $99,308
40,700 Added 121.12%
74,304 $140,000
Q1 2023

May 15, 2023

BUY
$1.03 - $2.62 $16,789 - $42,706
16,300 Added 94.2%
33,604 $60,000
Q2 2022

Aug 15, 2022

BUY
$1.28 - $4.84 $22,149 - $83,751
17,304 New
17,304 $22,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $26.6M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.